Search
for
Sort by
Research 241–270 of 1000+
- Prostate cancer update: 2007
- Prostate cancer update: 2007
- The eye and the skin in endocrine metabolic diseases
- Recommendations of endocrine treatment for patients with gender dysphoria
- Is dehydroepiandrosterone a hormone?
- Testosterone Treatment in Women – An Overview
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Alopecia and Hirsuties
- Diagnosis and treatments of hirsutism: where are we?
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Acne
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Sulfatase inhibitors: a patent review
- Congenital adrenal hyperplasia
- Pharmacological Treatment of Alopecia
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- The rationale for physiological testosterone replacement in women
- Hirsutism: diagnosis and treatment
- Managing polycystic ovary syndrome in primary care
- Gender Differences in Cardiac Hypertrophy
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Overcoming the Low Bioavailability of Apigenin: The Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration
- Endocrinology of Transgender Medicine
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study.
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial